Ascorbic acid
/ / / / /, Ascor, Berocca Pn, Infuvite, M.v.c. 9+, M.v.i, M.v.i. Lyophilized, Moviprep, Mvc, Plenvu, Vitaped (ascorbic acid) is a small molecule pharmaceutical. Ascorbic acid was first approved as M.v.i.-12 lyophilized on 1985-08-08. It is used to treat common cold, methemoglobinemia, penetrating wounds, scurvy, and tyrosinemias in the USA. It is known to target solute carrier family 23 member 2.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
Therapeutic Areas
Trade Name
FDA
EMA
Ascor, Ascorbic acid
CombinationsInfuvite, Moviprep, Plenvu (discontinued: Berocca pn, M.v.c. 9+, M.v.i., M.v.i. lyophilized, Mvc, Peg, sulfate, chloride, potassium chloride, ascorbate ascorbic acid, Vitaped)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Ascorbic acid
+
Polyethylene glycol 3350
+
Potassium chloride
+
Sodium ascorbate
+
Sodium chloride
+
Sodium sulfate
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| PLENVU | Salix Pharmaceuticals | N-209381 RX | 2018-05-04 | 1 products, RLD, RS |
| MOVIPREP | Salix Pharmaceuticals | N-021881 RX | 2006-08-02 | 1 products, RLD, RS |
Ascorbic acid
+
Biotin
+
Cyanocobalamin
+
Dexpanthenol
+
Ergocalciferol
+
Folic acid
+
Niacinamide
+
Pyridoxine hydrochloride
+
Riboflavin 5'-phosphate sodium
+
Thiamine hydrochloride
+
Vitamin a palmitate
+
Vitamin e
Alpha-tocopherol acetate
+
Ascorbic acid
+
Biotin
+
Cholecalciferol
+
Cyanocobalamin
+
Dexpanthenol
+
Folic acid
+
Niacinamide
+
Pyridoxine hydrochloride
+
Riboflavin 5'-phosphate sodium
+
Thiamine hydrochloride
+
Vitamin a palmitate
+
Vitamin k
Ascorbic acid
+
Biotin
+
Cholecalciferol
+
Cyanocobalamin
+
Dexpanthenol
+
Folic acid
+
Niacinamide
+
Pyridoxine
+
Riboflavin
+
Thiamine
+
Tocopherol acetate
+
Vitamin a
+
Vitamin k
Ascorbic acid
+
Biotin
+
Cyanocobalamin
+
Dexpanthenol
+
Ergocalciferol
+
Folic acid
+
Niacinamide
+
Pyridoxine hydrochloride
+
Riboflavin 5'-phosphate sodium
+
Thiamine hydrochloride
+
Vitamin a
+
Vitamin e
Ascorbic acid
+
Biotin
+
Cyanocobalamin
+
Dexpanthenol
+
Ergocalciferol
+
Folic acid
+
Niacinamide
+
Pyridoxine hydrochloride
+
Riboflavin
+
Thiamine hydrochloride
+
Vitamin a
+
Vitamin e
Ascorbic acid
+
Biotin
+
Cyanocobalamin
+
Dexpanthenol
+
Ergocalciferol
+
Folic acid
+
Niacinamide
+
Phytonadione
+
Pyridoxine hydrochloride
+
Riboflavin 5'-phosphate sodium
+
Thiamine hydrochloride
+
Vitamin a
+
Vitamin e
Ascorbic acid
+
Biotin
+
Cyanocobalamin
+
Dexpanthenol
+
Ergocalciferol
+
Folic acid
+
Niacinamide
+
Pyridoxine hydrochloride
+
Riboflavin 5'-phosphate sodium
+
Thiamine hydrochloride
+
Vitamin a
+
Vitamin e
+
Vitamin k
Ascorbic acid
+
Biotin
+
Cyanocobalamin
+
Ergocalciferol
+
Folic acid
+
Niacinamide
+
Pantothenic acid
+
Phytonadione
+
Pyridoxine
+
Riboflavin
+
Thiamine
+
Vitamin a palmitate
+
Vitamin e
Ascorbic acid
+
Biotin
+
Cyanocobalamin
+
Dexpanthenol
+
Ergocalciferol
+
Folic acid
+
Niacinamide
+
Pyridoxine
+
Riboflavin 5'-phosphate sodium
+
Thiamine
+
Vitamin a
+
Vitamin e
Ascorbic acid
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| ASCOR | McGuff Pharmaceuticals | N-209112 RX | 2017-10-02 | 1 products, RLD, RS |
Labels
FDA
EMA
Brand Name | Status | Last Update |
|---|---|---|
| 3 hand sanitizers | OTC monograph not final | 2014-11-15 |
| acetaminophen, ascorbic acid, chlorpheniramine maleate | Export only | 2024-05-08 |
| adult infuvite multiple vitamins | New Drug Application | 2025-08-18 |
| amoray premium instant hand sanitizer with aloe and vitamin e | OTC monograph not final | 2015-12-16 |
| anti-aging vitamin complex 7-in-1 broad spectrum spf15 sunscreen | OTC monograph not final | 2013-09-27 |
| antibacterial | OTC monograph not final | 2021-01-27 |
| antibacterial hand sanitizer cherry blossom scented | OTC monograph not final | 2020-07-09 |
| antibacterial hand sanitizer hawaiian coconut scented | OTC monograph not final | 2020-07-09 |
| antibacterial hand wipes | OTC monograph not final | 2020-10-27 |
| antibacterial moisturizing | OTC monograph not final | 2021-01-27 |
Show 372 more
Indications
FDA
EMA
Show 27 more
Agency Specific
FDA
EMA
Expiration | Code | ||
|---|---|---|---|
ASCORBIC ACID, ASCOR, MCGUFF | |||
| 2024-10-02 | ODE-160 | ||
Patent Expiration
Patent | Expires | Flag | FDA Information |
|---|---|---|---|
| Ascorbic Acid / Polyethylene Glycol 3350 / Potassium Chloride / Sodium Ascorbate / Sodium Chloride / Sodium Sulfate, Plenvu, Salix | |||
| 8999313 | 2033-09-10 | DP | |
| 9326969 | 2033-09-10 | U-2310 | |
| 9707297 | 2033-09-10 | DP | |
| 10016504 | 2033-09-10 | DP | |
| 10918723 | 2033-09-10 | U-2310 | |
| 9592252 | 2032-08-11 | DP | U-2310 |
| 10646512 | 2032-03-25 | DP | |
| 10780112 | 2032-03-09 | DP | |
| 10792306 | 2032-03-09 | DP | U-2310 |
| 11529368 | 2032-03-09 | DP | U-2310 |
| Ascorbic Acid / Polyethylene Glycol 3350 / Potassium Chloride / Sodium Ascorbate / Sodium Chloride / Sodium Sulfate, Moviprep, Salix Pharms | |||
| 7169381 | 2024-09-01 | DS, DP | |
| 7658914 | 2024-09-01 | DS, DP | |
ATC Codes
A: Alimentary tract and metabolism drugs
— A11: Vitamins
— A11G: Ascorbic acid (vitamin c), incl. combinations
— A11GA: Vitamin c products, plain
— A11GA01: Ascorbic acid
— A11GB: Vitamin c combinations
— A11GB01: Ascorbic acid and calcium
G: Genito urinary system and sex hormones
— G01: Gynecological antiinfectives and antiseptics
— G01A: Antiinfectives and antiseptics, excl. combinations with corticosteroids
— G01AD: Organic acids, gynecological
— G01AD03: Ascorbic acid
S: Sensory organ drugs
— S01: Ophthalmologicals
— S01X: Other ophthalmologicals in atc
— S01XA: Other ophthalmologicals in atc
— S01XA15: Ascorbic acid
HCPCS
No data
Clinical
Clinical Trials
2087 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Covid-19 | D000086382 | — | U07.1 | 8 | 24 | 23 | 2 | 37 | 85 |
| Diabetes mellitus | D003920 | EFO_0000400 | E08-E13 | 7 | 7 | 8 | 7 | 32 | 59 |
| Anemia | D000740 | EFO_0004272 | D64.9 | — | 1 | 10 | 9 | 37 | 57 |
| Iron deficiencies | D000090463 | — | E61.1 | — | 1 | 7 | 8 | 36 | 51 |
| Iron-deficiency anemia | D018798 | — | D50 | — | — | 7 | 9 | 29 | 45 |
| Sepsis | D018805 | EFO_0001420 | A41.9 | 3 | 15 | 11 | 4 | 15 | 44 |
| Septic shock | D012772 | — | A48.3 | 3 | 12 | 13 | 3 | 10 | 36 |
| Type 2 diabetes mellitus | D003924 | EFO_0001360 | E11 | 5 | 7 | 3 | 6 | 15 | 34 |
| Obesity | D009765 | EFO_0001073 | E66.9 | 3 | 1 | 1 | 1 | 28 | 34 |
| Infections | D007239 | EFO_0000544 | — | 5 | 6 | 10 | 2 | 12 | 33 |
Show 222 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Healthy volunteers/patients | — | — | — | 21 | 4 | 3 | — | 40 | 67 |
| Syndrome | D013577 | — | — | 5 | 16 | 6 | — | 23 | 45 |
| Pancreatic neoplasms | D010190 | EFO_0003860 | C25 | 11 | 16 | 4 | — | 2 | 27 |
| Asthma | D001249 | EFO_0000270 | J45 | 2 | 3 | 5 | — | 14 | 23 |
| Oxidative stress | D018384 | EFO_1001905 | — | 1 | 3 | 4 | — | 13 | 21 |
| Pneumonia | D011014 | EFO_0003106 | J18 | — | 7 | 4 | — | 8 | 17 |
| Lung neoplasms | D008175 | — | C34.90 | 1 | 6 | 2 | — | 6 | 14 |
| Metabolic syndrome | D024821 | EFO_0000195 | E88.810 | 2 | 1 | 2 | — | 9 | 13 |
| Osteoarthritis | D010003 | EFO_0002506 | M15-M19 | — | 2 | 1 | — | 9 | 12 |
| Lymphoma | D008223 | — | C85.9 | 1 | 6 | 2 | — | 4 | 12 |
Show 181 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Neoplasms | D009369 | — | C80 | 8 | 8 | — | — | 7 | 20 |
| Multiple myeloma | D009101 | — | C90.0 | 7 | 11 | — | — | 3 | 17 |
| Chronic obstructive pulmonary disease | D029424 | EFO_0000341 | J44.9 | 2 | 1 | — | — | 14 | 17 |
| Myelodysplastic syndromes | D009190 | — | D46 | 3 | 11 | — | — | 4 | 16 |
| Preleukemia | D011289 | — | — | 3 | 9 | — | — | 3 | 13 |
| Plasma cell neoplasms | D054219 | — | — | 7 | 9 | — | — | 1 | 13 |
| Non-small-cell lung carcinoma | D002289 | — | — | 4 | 6 | — | — | 3 | 11 |
| Anxiety | D001007 | EFO_0005230 | F41.1 | — | 1 | — | — | 9 | 10 |
| Hypersensitivity | D006967 | EFO_0003785 | T78.40 | — | 2 | — | — | 7 | 9 |
| Knee osteoarthritis | D020370 | EFO_0004616 | M17 | — | 2 | — | — | 5 | 7 |
Show 223 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Alzheimer disease | D000544 | EFO_0000249 | F03 | 2 | — | — | — | 3 | 5 |
| Fibromyalgia | D005356 | EFO_0005687 | M79.1 | 1 | — | — | — | 4 | 5 |
| Sclerosis | D012598 | — | — | 2 | — | — | — | 3 | 5 |
| Sleep apnea syndromes | D012891 | EFO_0003877 | G47.3 | 1 | — | — | — | 4 | 5 |
| Systemic lupus erythematosus | D008180 | EFO_0002690 | M32 | 1 | — | — | — | 4 | 5 |
| Agnosia | D000377 | EFO_0007136 | F88 | 1 | — | — | — | 3 | 4 |
| Myofascial pain syndromes | D009209 | EFO_1001054 | — | 1 | — | — | — | 3 | 4 |
| Blood pressure | D001794 | EFO_0004325 | — | 1 | — | — | — | 3 | 4 |
| Amyotrophic lateral sclerosis | D000690 | EFO_0000253 | G12.21 | 2 | — | — | — | 2 | 4 |
| Motor neuron disease | D016472 | EFO_0003782 | G12.2 | 2 | — | — | — | 2 | 4 |
Show 70 more
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Cognitive dysfunction | D060825 | — | G31.84 | — | — | — | — | 9 | 9 |
| Anxiety disorders | D001008 | EFO_0006788 | F41.1 | — | — | — | — | 8 | 8 |
| Lung diseases | D008171 | EFO_0003818 | J98.4 | — | — | — | — | 8 | 8 |
| Healthy diet | D000072001 | — | — | — | — | — | — | 7 | 7 |
| Obstructive lung diseases | D008173 | — | — | — | — | — | — | 6 | 6 |
| Emergencies | D004630 | — | — | — | — | — | — | 6 | 6 |
| Sarcopenia | D055948 | EFO_1000653 | M62.84 | — | — | — | — | 6 | 6 |
| Cerebral palsy | D002547 | — | G80 | — | — | — | — | 5 | 5 |
| Chronic disease | D002908 | — | — | — | — | — | — | 5 | 5 |
| Autonomic nervous system diseases | D001342 | EFO_0009532 | G90 | — | — | — | — | 4 | 4 |
Show 442 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | Ascorbic acid |
| INN | ascorbic acid |
| Description | L-ascorbic acid is the L-enantiomer of ascorbic acid and conjugate acid of L-ascorbate. It has a role as a coenzyme, a flour treatment agent, a food antioxidant, a plant metabolite, a cofactor, a skin lightening agent, a geroprotector and a food colour retention agent. It is an ascorbic acid and a vitamin C. It is a conjugate acid of a L-ascorbate. It is an enantiomer of a D-ascorbic acid. |
| Classification | Small molecule |
| Drug class | — |
| Image (chem structure or protein) |  |
| Structure (InChI/SMILES or Protein Sequence) | O=C1O[C@H]([C@@H](O)CO)C(O)=C1O |
Identifiers
| PDB | — |
| CAS-ID | 50-81-7 |
| RxCUI | — |
| ChEMBL ID | CHEMBL196 |
| ChEBI ID | 29073 |
| PubChem CID | 54670067 |
| DrugBank | DB00126 |
| UNII ID | PQ6CK8PD0R (ChemIDplus, GSRS) |
Target
Agency Approved
No data
Alternate
SLC23A2
SLC23A2
Organism
Homo sapiens
Gene name
SLC23A2
Gene synonyms
KIAA0238, NBTL1, SLC23A1, SVCT2, YSPL2
NCBI Gene ID
Protein name
solute carrier family 23 member 2
Protein synonyms
hSVCT2, Na(+)/L-ascorbic acid transporter 2, Nucleobase transporter-like 1 protein, Sodium-dependent vitamin C transporter 2, sodium-dependent vitamin C transporter-2, solute carrier family 23 (ascorbic acid transporter), member 2, solute carrier family 23 (nucleobase transporters), member 1, solute carrier family 23 (nucleobase transporters), member 2, testicular secretory protein Li 48, Yolk sac permease-like molecule 2
Uniprot ID
Mouse ortholog
Slc23a2 (54338)
solute carrier family 23 member 2 (Q9JM78)
Variants
No data
Financial
Revenue by drug
$
€
£
₣
No data
Estimated US medical usage
Ascorbic acid
Total medical expenditures per year (USD, in millions)
Mock data
Subscribe for the real data
Subscribe for the real data
Number of persons purchased
Mock data
Subscribe for the real data
Subscribe for the real data
Number of purchases
Mock data
Subscribe for the real data
Subscribe for the real data
Refill frequency
Mock data
Subscribe for the real data
Subscribe for the real data
Price per prescription (USD)
Mock data
Subscribe for the real data
Subscribe for the real data
Tabular view
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 138,991 documents
View more details
Safety
Black-box Warning
Black-box warning for: Chromagen, Citranatal, Citranatal assure, Citranatal essence, Enlyte, Ferralet 90, Healthy mamabe well rounded, Hematogen fa, Hematogen forte, Marnatal f, Moms choice rx, Natafort, Nestabs, Nestabs dha, Nestabs one, Niferex, O-cal prenatal vitamin, Pnv prenatal plus multivitamin, Pnv prenatal vitamin, Pnv-dha, Pnv-omega, Pnv-select, Pr natal 400, Pr natal 400 ec, Pr natal 430, Pr natal 430 ec, Pre-tabs dha, Prenata, Prenatal plus multivitamin plus dha minicaps, Prenate dha, Prenate elite, Prenate enhance, Prenate essential, Prenate mini, Prenate pixie, Prenate restore, Select ob, Select-ob plus dha, Tristart dha, Vitafol, Vitafol fe plus, Vitafol ob, Vitafol-ob plus dha
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
13,315 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use